Search

everythinglearnresearchcommunity

for

Search:↓

Surgery to lower high testosterone in postmenopausal women with certain ovarian tumors doesn't significantly affect their metabolism.

Increased HSD11B1 enzyme expression is linked to higher body fat and insulin resistance.

High afamin levels are linked to metabolic syndrome and may predict its development in women with insulin resistance.

Teens with PCOS and a mom with PCOS have higher insulin resistance and lower adiponectin levels, which could signal early metabolic problems.

Women with PCOS and higher androgen levels are more likely to have fatty liver disease.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Early-onset baldness is linked to genetics, lifestyle, and can indicate higher risk for heart and metabolic diseases, and affects mental health.

People with plantar corns and calluses may have a higher chance of having metabolic syndrome.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

Men and women respond differently to drugs for COVID-19, high cholesterol, and diabetes, which suggests a need for personalized treatments.

Women with PCOS are more likely to have fatty liver disease, especially if they have metabolic problems.

Testosterone and dihydrotestosterone have similar effects on body composition and metabolic health in men.

Hidden fungal infections might cause heart disease and clogged arteries.

Overweight women with PCOS have higher levels of certain hormones that could indicate a higher risk of heart and metabolic problems.

Rosuvastatin improves lipid levels, reduces inflammation, but worsens insulin sensitivity in men with early-onset hair loss.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

Women with PCOS have higher levels of certain blood clotting factors, suggesting a greater risk of cardiovascular issues.

Young men with early hair loss have slightly worse blood sugar and fat levels, suggesting possible health risks and need for monitoring.

Testosterone therapy in transgender men has both desired effects like increased muscle mass and potential health risks such as higher cardiovascular risk.

Lung and liver macrophages protect our tissues and their dysfunction can cause various diseases.

More high-quality research is needed to recommend flavonoids and saponins for clinical use.

Different treatments for PCOS should be tailored to the individual, including lifestyle changes and various medications.

Eating a high inositol diet significantly improves insulin resistance and hormone levels in women with PCOS.

Insulin resistance and high male hormone levels are major causes of Polycystic Ovary Syndrome.

Simvastatin may help manage symptoms in women with non-classic congenital adrenal hyperplasia by lowering cholesterol and certain hormone levels.

Chronic kidney disease can cause hair loss, which may be related to zinc deficiency or certain medications, and sometimes hair grows back when the underlying issue is treated.

Young women with PCOS and no other heart risk factors have normal heart function.

Skin tags in obese individuals may indicate higher cardiovascular risk.

Testosterone with finasteride improved muscle and bone health in men with spinal cord injury.